Baird lowered the firm’s price target on Synopsys (SNPS) to $630 from $644 and keeps an Outperform rating on the shares. The firm views the weakness in the shares following its results as a buying opportunity as the company offered positive views on EBIT margin improvement while the outlook for earnings and free cash flow generally matches expectations.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNPS:
- Synopsys Reports Strong 2024 Financial Results
- Synopsys (SNPS) Stock Falls 7% as Guidance Underwhelms
- Closing Bell Movers: Five Below up 13%, PVH slips 6% on earnings
- Synopsys falls 7% to $546.00 after issuing below-consensus Q1 guidance
- Synopsys sees FY25 operating cash flow ~$1.8B; free cash flow ~$1.6B